Method of using and compositions comprising immunomodulatory compounds for the treatment and management of myeloproliferative diseases

Details for Australian Patent Application No. 2004319816 (hide)

Owner Celgene Corporation

Inventors Zeldis, Jerome, B.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2004319816

PCT Pub. Number WO2005/112928

Filing date 5 May 2004

Wipo publication date 1 December 2005

International Classifications

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

Event Publications

30 November 2006 PCT application entered the National Phase

  PCT publication WO2005/112928 Priority application(s): WO2005/112928

2 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004319822-Method of making stem cells from differentiated cells cross-reference to related applications

2004319815-Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases